9 Einträge gefunden

1. Antithrombotische Therapie der peripheren arterielle Verschlusskrankheit

   1. Bauersachs, Rupert
   2. Espinola-Klein, Christine
   3. Lawall, Holger
   4. Storck, M
   5. Zeller, T
   6. Debus, Sebastian

   2020 - Forschungsinformationssystem des UKE
2. Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: A translational review of current literature

   1. Reichart, D
   2. Magnussen, C
   3. Zeller, T
   4. Blankenberg, S

   2019 - Forschungsinformationssystem des UKE
3. Predictive value of low testosterone concentrations regarding coronary heart disease and mortality in men and women - evidence from the FINRISK97 study

   1. Zeller, T
   2. Appelbaum, S
   3. Kuulasmaa, K
   4. Palosaari, T
   5. Blankenberg, S
   6. Jousilahti, P
   7. Salomaa, V

   2019 - Forschungsinformationssystem des UKE
4. Plasma levels of hepatocyte growth factor and placental growth factor predict mortality in a general population: a prospective cohort study

   1. Santalahti, K
   2. Havulinna, A
   3. Maksimow, M
   4. Zeller, T
   5. Blankenberg, S
   6. Vehtari, A
   7. Joensuu, H

   2017 - Forschungsinformationssystem des UKE
5. PO-58 - Cardiovascular risk profile in survivors of adult cancer - results from the general population study

   1. Panova-Noeva, M
   2. Hermanns, I M
   3. Schulz, A
   4. Laubert-Reh, D
   5. Zeller, T
   6. Blankenberg, S
   7. Spronk, H M

   2016 - Forschungsinformationssystem des UKE
6. Inflammatory bowel disease (IBD) locus 12: is glutathione peroxidase-1 (GPX1) the relevant gene?

   1. Häuser, F
   2. Rossmann, H
   3. Laubert-Reh, D
   4. Wild, P S
   5. Zeller, T
   6. Müller, C
   7. Neuwirth, S

   2015 - Forschungsinformationssystem des UKE
7. The Gutenberg Health Study, Die Gutenberg Gesundheitsstudie

   1. Wild, P S
   2. Zeller, T
   3. Beutel, M
   4. Blettner, M
   5. Dugi, K A
   6. Lackner, K J
   7. Pfeiffer, N

   2012 - Forschungsinformationssystem des UKE
8. Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes

   1. Luotola, K
   2. Pietilä, A
   3. Zeller, T
   4. Moilanen, L
   5. Kähönen, M
   6. Nieminen, M S
   7. Kesäniemi, Y A

   2011 - Forschungsinformationssystem des UKE
9. Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study

   1. Tregouet, D A
   2. Schnabel, R
   3. Alessi, M C
   4. Godefroy, T
   5. Declerck, P J
   6. Nicaud, V
   7. Munzel, T

   2009 - Forschungsinformationssystem des UKE